Burrill & Co.

NEW YORK (GenomeWeb News) – Strand Life Sciences today said that financial services firm Burrill & Co. has invested in the firm's Series B round of financing.

This article has been updated to clarify that the bankruptcy filing only applies to the Gene Logic subsidiary.
By a GenomeWeb staff reporter

Under the agreement, the two companies will co-invest into life science opportunities in China.

The building, estimated to cost $6 million, would include space configurable for either laboratory or light industrial use, designed for life-sci users that do not need the intensive use of utilities available in more traditional lab buildings.

Direct-to-consumer genetic testing companies have offered to test families separated at the southern US border, but that raises ethical issues.

CNBC reports that confirming a positive result from 23andMe's BRCA health report can be expensive.

The New York Times reports on a project to develop a tree DNA database to uncover illegal logging.

In PLOS this week: links between gut microbiome and colorectal cancer mutations, targeted sequencing uncovers genetic susceptibilities to epilepsy in Koreans, and more.